SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007082
Filing Date
2019-05-14
Accepted
2019-05-14 16:16:22
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 564933
2 ex31.htm EX-31 31595
3 ex32.htm EX-32 8122
  Complete submission text file 0001493152-19-007082.txt   3179644

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ocx-20190331.xml EX-101.INS 462387
5 XBRL SCHEMA FILE ocx-20190331.xsd EX-101.SCH 45457
6 XBRL CALCULATION FILE ocx-20190331_cal.xml EX-101.CAL 50806
7 XBRL DEFINITION FILE ocx-20190331_def.xml EX-101.DEF 149972
8 XBRL LABEL FILE ocx-20190331_lab.xml EX-101.LAB 301108
9 XBRL PRESENTATION FILE ocx-20190331_pre.xml EX-101.PRE 227598
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 19822922
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences